|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03869 HOSPITAL CORP
Nominal 
4.800 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 1,427,733 | 24.916% | 1,142,951 | 520,290 | 399,214 | 410,883 |
| Cost of Sales | (1,188,373) | 19.787% | (992,073) | (306,063) | (204,885) | (237,017) |
| Gross Profit | 239,360 | 58.645% | 150,878 | 214,227 | 194,329 | 173,866 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 884 | -- | (462,150) | (578,458) | (683,296) | (1,581) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 216,204 | -- | (532,628) | (449,102) | (435,823) | 195,566 | |
| Taxation | (47,860) | -- | 4,031 | 86,706 | 14,754 | (26,120) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (36,960) | -- | 47,649 | 81,687 | 16,727 | (18,546) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 131,384 | -- | (480,948) | (280,709) | (404,342) | 150,900 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (1,706) | -68.172% | (5,360) | 14,028 | 35,982 | (18,534) |
| Depreciation & Amortisation | 62,862 | -0.659% | 63,279 | 41,145 | 42,902 | 43,826 |
| Directors' Emoluments | 2,262 | -64.595% | 6,389 | 5,069 | 11,145 | 8,670 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 95.600 | -- | -348.000 | -203.100 | -292.600 | 109.200 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.602 | -- | 1.036 | 0.963 | 0.604 | 0.456 |
| NBV per share ($) | 2.743 | -- | 1.850 | 5.774 | 7.816 | 10.732 |
| Remarks: | Real time quote last updated: 18/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -18,718,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.140 |
| NBV Per Share (¥) | RMB 2.608 |